FDAnews Drug Daily Bulletin

Fresenius Kabi Pulls Sensocaine-MPF Injection

May 4, 2016

Fresenius Kabi USA is recalling one lot of its injectable anesthetic Sensorcaine-MPF after an inspection turned up glass-like particulate matter in the product’s reserve samples.

The company warns that use of the injections, distributed between March 4 and March 21, may lead to inflammation, injury or vasculature blockage of eye nerves. Thus far, Fresenius has received no adverse event reports pertaining to the recall.

Read the recall notice here: www.fdanews.com/04-27-16-FreseniusRecall.pdf.


View More Stories